1. National Cancer Institute. Previous version: SEER sancer statistics review, 1975–2011 [Internet]. Bethesda (MD): National Cancer Institute;cited 2014 Oct 7. .
2. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014; 140:317–322.
3. Brito JP, Morris JC, Montori VM. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ. 2013; 347:f4706.
![crossref](/image/icon/bnr_ref_cross.gif)
4. Pacini F, Castagna MG. Approach to and treatment of differentiated thyroid carcinoma. Med Clin North Am. 2012; 96:369–383.
6. How J, Tabah R. Explaining the increasing incidence of differentiated thyroid cancer. CMAJ. 2007; 177:1383–1384.
![crossref](/image/icon/bnr_ref_cross.gif)
7. Haselkorn T, Bernstein L, Preston-Martin S, Cozen W, Mack WJ. Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972–1995. Cancer Causes Control. 2000; 11:163–170.
10. Schottenfeld D, Fraumeni JF Jr. Cancer Epidemiology and Prevention. Bethesda (MD): Oxford University Press;2006.
11. Sprague BL, Warren Andersen S, Trentham-Dietz A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control. 2008; 19:585–593.
12. Morris LG, Sikora AG, Myssiorek D, DeLacure MD. The basis of racial differences in the incidence of thyroid cancer. Ann Surg Oncol. 2008; 15:1169–1176.
13. Iribarren C, Haselkorn T, Tekawa IS, Friedman GD. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer. 2001; 93:745–750.
14. Haselkorn T, Stewart SL, Horn-Ross PL. Why are thyroid cancer rates so high in Southeast Asian women living in the United States? The bay area thyroid cancer study. Cancer Epidemiol Biomarkers Prev. 2003; 12:144–150.
15. Ron E, Kleinerman RA, Boice JD Jr, LiVolsi VA, Flannery JT, Fraumeni JF Jr. A population-based case-control study of thyroid cancer. J Natl Cancer Inst. 1987; 79:1–12.
17. World Health Organization, International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence world-wide in 2012 [Internet]. Lyon: International Agency for Research on Cancer;2015. cited 2015 Aug 11. Available from:
http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
18. Lee SY. Thyroid cancer screening. J Korean Med Assoc. 2015; 58:684–687.
![crossref](/image/icon/bnr_ref_cross.gif)
19. Deen MH, Burke KM, Janitz A, Campbell J. Cancers of the thyroid: overview and statistics in the United States and Oklahoma. J Okla State Med Assoc. 2016; 109:333–338.
20. National Cancer Institute, Surveillance, Epidemiology, and End Results Program. Thyroid cancer facts and figures [Internet]. Bethesda (MD): National Cancer Institute;cited 2015 Sep 20. Available from:
http://seer.cancer.gov/statfacts/html/thyro.html.
26. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International Classification of Diseases for Oncology. 3rd ed. Geneva: World Health Organization;2000.
27. Robertson CT. Scaling cost-sharing to wages: how employers can reduce health spending and provide greater economic security. Yale J Health Policy Law Ethics. 2014; 14:239–295.
28. Nagar S, Aschebrook-Kilfoy B, Kaplan EL, Angelos P, Grogan RH. Age of diagnosing physician impacts the incidence of thyroid cancer in a population. Cancer Causes Control. 2014; 25:1627–1634.
31. Zheng T, Holford TR, Chen Y, Ma JZ, Flannery J, Liu W, et al. Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935–1992. Int J Cancer. 1996; 67:504–509.